Vaccine News and Research

Latest Vaccine News and Research

Bioniche granted additional patent for mycobacterial cell wall technology

Bioniche Life Sciences Inc., a research-based, technology-driven human and animal health biopharmaceutical company, today announced that it has had a new patent issued by the United States Patent and Trademark Office (USPTO) on its core mycobacterial cell wall technology.

18 May 2005

Vaccine may prevent cigarette addiction

Clinical trials on a new vaccine against smoking has given hope to those trying to quit. The vaccine could also prevent cigarette addiction.

17 May 2005

The Gates Foundation approach to the world's health problems has its critics

A recent article in The Lancet criticized the premise that a Grand Challenge to scientific and technological know-how is the best route to combating malaria, HIV/AIDS, tuberculosis and other diseases that kills millions of people each year.

16 May 2005

Bill Gates calls on world leaders to seize opportunity to improve health

In a major address today to international health officials, Bill Gates said the world now has a "historic chance" to achieve dramatic improvements in health, and called on governments, the scientific community, and the private sector to more aggressively fight the diseases that affect hundreds of millions of the world's poorest people each year.

16 May 2005

Vaccine candidate to treat nicotine addiction shows promise

Cytos Biotechnology AG has announced that its vaccine candidate CYT002-NicQb to treat nicotine addiction has achieved proof of efficacy.

16 May 2005

Polio vaccination launched despite objection from religious group

A partnership between Mali's Ministry of Health and the UN children's fund UNICEF launched a third and final phase of polio immunisation on May 13th, aiming to reach 3.6 million children. Regardless of recent opposition from religious leaders, the three day programme plans to inoculate all children five years and under.

15 May 2005

Annual flu shots to be recommended for everyone in the U.S.

Public health advocates in the U.S. are predicting that within five years, annual flu shots will be recommended by the government for every American and not just young children, the elderly and other at-risk people.

15 May 2005

Anti-nicotine vaccine to help smokers is promising

Swiss researchers say they have had some encouraging results with an experimental anti-nicotine vaccine.

15 May 2005

Miserable mumps makes a comeback

There is concern in the UK at the growing number of outbreaks of mumps among children and young people.

12 May 2005

No link between MMR jab and Crohn's disease

A research paper published in 1998, which claimed the MMR jab was in some way linked to autism and Crohn's disease, the inflammatory bowel disease, caused MMR vaccination numbers to fall across the country.

12 May 2005

Mystery respiratory disease sweeping through greyhound population

Dozens of dogs in the U.S. are dying from a mysterious respiratory disease which is sweeping greyhound tracks across the country, and race track owners are being forced to halt racing as researchers hunt for a vaccine to control the outbreak.

12 May 2005

Insulin - possible vaccine against type 1 diabetes

It has taken scientists at the University of Miami's Diabetes Research Institute eight long years of painstaking research, but they believe they have finally pinned down Insulin, the hormone most closely linked to diabetes, to be the cause of the inherited form of the blood sugar disease.

11 May 2005

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against some of the most deadly agents of bioterrorism including anthrax, botulinum toxin, Ebola virus, pneumonic plague, smallpox and tularemia.

11 May 2005

Six million doses of polio vaccine shipped to Yemen

Six million doses of monovalent oral polio vaccine type 1 (mOPV1) have been shipped to Yemen, as part of emergency measures to stop the ongoing polio outbreak in the country.

11 May 2005

Broken bones may reduce risk of ovarian cancer

The pain and suffering of a broken bone may yield an unexpected benefit – a reduced risk of ovarian cancer.

10 May 2005

Vaccine against Alzheimer's disease may still be on the cards

A new, but modified, trial of an Alzheimer's vaccine has begun in the U.S. despite an earlier one being abandoned in 2002 due to safety concerns.

10 May 2005

Laboratory model of immune system overcomes ethical constraints on studies of hematopoietic stem cells in humans

Scientists at St. Jude Children’s Research Hospital have joined with colleagues at several other institutions to develop a laboratory model of the human immune system. This model will allow scientists to study ways for improving the results of hematopoietic stem cell (HSC) transplantation without putting patients at risk.

10 May 2005

Fragile US vaccine system needs improvement

A comprehensive system of vaccine development in the U.S. resulted in a reduction of 87 to more than 99 percent in illness from ten vaccine-preventable diseases during the twentieth century. These dramatic successes should not be taken for granted, however, as the vaccine system now faces numerous challenges in manufacturing and development, according to a review article in the May/June issue of Health Affairs.

10 May 2005

Americans willing to pay more for greater vaccine coverage

How much is it worth to you and your family to have a health insurance plan that covers the latest innovations in adult and childhood vaccines for certain types of cancer or even influenza and pneumonia?

10 May 2005

Expert analyzes why manufacturers have gradually abandoned vaccines

Recent shortages of vaccines, most recently the flu vaccine during the past winter, are not short-term glitches--they reflect long-term problems in the vaccine industry. A variety of social, legal and economic forces have caused pharmaceutical companies to withdraw their commitment to vaccines, according to pediatrician and vaccine expert Paul A. Offit, M.D., chief of Infectious Diseases at The Children's Hospital of Philadelphia.

10 May 2005